A systematic review 1 including 43 studies with a total of 1,168 subjects with recurrent, symptomatic, malignant pleural effusions, was abstracted in DARE. The agents studied were doxycycline, minocycline, tetracycline, bleomycin, cisplatin, doxorubicin, etoposide, fluorouracil, interferon-beta, mitomycin-c, corynebacterium parvum, methylprednisolone, and talc. Only 4 agents (tetracycline, bleomycin, C parvum and talc) were studied in more than 100 patients.
The complete response rate after treatment with chemical pleurodesis was on average 64% (752/1169). The success rate of the pleurodesis agents was 0% with etoposide, 54% with bleomycin, 67% with tetracyclines, 76% with corynebacterium parvum, and 93% with talc. Pain (23%) and fever (19%) were the most commonly reported adverse effects.
Comment: The quality of evidence is downgraded by indirectness (there is a lack of direct comparability of the different agents) and sparse data.
Primary/Secondary Keywords